CUPR Cuprina Holdings (Cayman) Limited

NAS · US · Healthcare · Medical Instruments & Supplies · cuprina.com.sg

1.990USD-8.29%Mkt Cap: 13.94M $P/E: —1d ago

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a lin…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$146.44BUSDP/E 47.5

EssilorLuxottica Société anonyme

$73.12BUSDP/E 27.4

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$25.79BUSDP/E 46.9

DIM

Sartorius Stedim Biotech S.A.

$23.14BUSDP/E 72.7

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.50BUSDP/E 73.0

SOLV

Solventum Corporation

$14.62BUSDP/E 10.5

BAX

Baxter International Inc.

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap13.94M USD

Enterprise Value6.03M USD

Revenue (TTM)49.89K USD

Gross Profit-645 USD

Net Income (TTM)-4.67M USD

Revenue/Share0.02 USD

Last Price1.990 USD

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees10

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-1.26

EV/Revenue120.80

P/S304.61

P/B1.47

EPS (TTM)-1.35

EPS (Forward)—

52W Range

1.4454% of range14.80

52W High14.80 USD

52W Low1.445 USD

Profitability

Gross Margin-1.29%

Oper. Margin-10568.35%

EBITDA Margin0.00%

Profit Margin-9366.75%

ROE-92.44%

ROA-54.95%

Growth

Revenue Growth267.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF-9.13M USD

CapEx (TTM)58.23K USD

FCF Margin-12016.38%

FCF Yield-43.02%

Net Debt208.93K USD

Net Debt/EBITDA-0.04

Balance Sheet

Debt/Equity0.10

Current Ratio2.35

Quick Ratio1.03

Book Value/Sh1.47 USD

Cash/Share1.20 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Splits

Last Split1:8

Split DateMay 27, 2026

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.5.24M

Float2.01M

Insiders0.00%

Institutions0.79%

Short Interest

Short Ratio0.1d

Short % Float0.38%

Short % Out.0.13%

Shares Short3.52K

Short (prev mo.)11.26K

Technical

SMA 502.747 (-27.5%)

SMA 2003.185 (-37.5%)

Beta—

S&P 52W Chg16.45%

Avg Vol (30d)191.55K

Avg Vol (10d)201.05K

Technical Indicators

RSI (14)40.7

MACD-0.1807

MACD Signal-0.2251

MACD Hist.+0.0444

BB Upper3.209 USD

BB Middle2.228 USD

BB Lower1.246 USD

BB Width88.11%

ATR (14)0.3574 USD

Vol Ratio (20d)0.34x